<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_inflammatory" title="Role of Microparticles in the Pathogenesis of Inflammatory Joint Diseases" shortTitle="inflammatory" author="Magdalena Krajewska-Włodarczyk, Agnieszka Owczarczyk-Saczonek, Zbigniew Żuber, Maja Wojtkiewicz, Joanna Wojtkiewicz" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/1422-0067/20/21/5453/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
5.	LS	5.
Microparticles	NNS	microparticle
as	IN	as
an	DT	a
Indicator	NN	indicator
of	IN	of
Disease	NNP	Disease
Activity	NNP	Activity
</s>
</head>
<p>
<s type="decl">
Microparticles	NNS	microparticle
have	VBP	have
been	VBN	be
attracting	VBG	attract
increasing	VBG	increase
attention	NN	attention
as	IN	as
potential	JJ	potential
indicators	NNS	indicator
of	IN	of
eukaryotic	JJ	eukaryotic
cell	NN	cell
activation	NN	activation
.	.	.
</s>
<s type="sub">
They	PRP	they
could	MD	could
provide	VB	provide
valuable	JJ	valuable
information	NN	information
on	IN	on
inflammatory	JJ	inflammatory
processes	NNS	process
in	IN	in
progress	NN	progress
,	,	,
disease	NN	disease
activity	NN	activity
,	,	,
and	CC	and
the	DT	the
response	NN	response
to	IN	to
treatment	NN	treatment
as	RB	as
well	RB	well
as	IN	as
prognosis	NN	prognosis
as	IN	as
a	DT	a
disease	NN	disease
assessment	NN	assessment
indicator	NN	indicator
.	.	.
</s>
</p>
<p>
<s type="decl">
Hsu	NNP	Hsu
et	FW	et
al.	NNS	al.
demonstrated	VBD	demonstrate
that	IN	that
release	NN	release
of	IN	of
MPs	NNS	MP
from	IN	from
platelets	NNS	platelet
activated	VBN	activate
with	IN	with
collagen	NN	collagen
decreased	VBD	decrease
considerably	RB	considerably
after	IN	after
the	DT	the
activity	NN	activity
of	IN	of
kinase	NN	kinase
BTK	NNP	BTK
was	VBD	be
inhibited	VBN	inhibit
.	.	.
</s>
<s type="decl">
Reduction	NN	reduction
of	IN	of
PMPs	NNP	PMP
numbers	NNS	number
in	IN	in
other	JJ	other
studies	NNS	study
with	IN	with
BTK	NNP	BTK
inhibitor	NN	inhibitor
in	IN	in
platelet	NN	platelet
cultures	NNS	culture
was	VBD	be
associated	VBN	associate
with	IN	with
a	DT	a
decrease	NN	decrease
in	IN	in
production	NN	production
and	CC	and
the	DT	the
release	NN	release
of	IN	of
inflammatory	JJ	inflammatory
cytokines	NNS	cytokine
IL-6	NNP	IL-6
and	CC	and
IL-8	NNP	IL-8
.	.	.
</s>
<s type="decl">
A	DT	a
considerable	JJ	considerable
increase	NN	increase
in	IN	in
the	DT	the
number	NN	number
of	IN	of
platelet	NN	platelet
,	,	,
monocyte	NN	monocyte
,	,	,
and	CC	and
lymphocyte-derived	JJ	lymphocyte-derived
microparticles	NNS	microparticle
(	-LRB-	(
CD3	NNP	CD3
,	,	,
CD19	FW	CD19
)	-RRB-	)
has	VBZ	have
been	VBN	be
observed	VBN	observe
in	IN	in
RA	NNP	RA
patients	NNS	patient
with	IN	with
high	JJ	high
disease	NN	disease
activity	NN	activity
.	.	.
</s>
<s type="decl">
Rodrigez-Cario	NNP	Rodrigez-Cario
et	FW	et
al.	FW	al.
examined	VBD	examine
the	DT	the
amount	NN	amount
of	IN	of
circulating	VBG	circulate
microparticles	NNS	microparticle
and	CC	and
their	PRP$	their
origin	NN	origin
in	IN	in
114	CD	114
RA	NN	RA
patients	NNS	patient
.	.	.
</s>
<s type="decl">
The	DT	the
total	JJ	total
number	NN	number
of	IN	of
MPs	NNS	MP
in	IN	in
platelet	NN	platelet
poor	JJ	poor
plasma	NN	plasma
was	VBD	be
much	RB	much
higher	JJR	high
in	IN	in
individuals	NNS	individual
with	IN	with
arthritis	NN	arthritis
compared	VBN	compare
to	IN	to
a	DT	a
group	NN	group
of	IN	of
healthy	JJ	healthy
individuals	NNS	individual
.	.	.
</s>
<s type="decl">
The	DT	the
occurrence	NN	occurrence
of	IN	of
different	JJ	different
MPs	NNS	MP
subtypes	NNS	subtype
in	IN	in
this	DT	this
study	NN	study
differed	VBD	differ
considerably	RB	considerably
in	IN	in
the	DT	the
RA	NN	RA
group	NN	group
and	CC	and
was	VBD	be
associated	VBN	associate
with	IN	with
the	DT	the
clinical	JJ	clinical
course	NN	course
of	IN	of
joint	JJ	joint
inflammation	NN	inflammation
:	:	:
</s>
<s type="decl">
The	DT	the
amount	NN	amount
of	IN	of
endothelial	JJ	endothelial
MPs	NN	MP
was	VBD	be
associated	VBN	associate
with	IN	with
the	DT	the
disease	NN	disease
duration	NN	duration
,	,	,
the	DT	the
amount	NN	amount
of	IN	of
granulocyte	NN	granulocyte
MPs	NNS	MP
was	VBD	be
associated	VBN	associate
with	IN	with
the	DT	the
disease	NN	disease
activity	NN	activity
as	IN	as
assessed	VBN	assess
by	IN	by
DAS28	NNP	DAS28
,	,	,
whereas	IN	whereas
the	DT	the
amount	NN	amount
of	IN	of
monocyte-derived	JJ	monocyte-derived
MPs	NNP	MPs
was	VBD	be
associated	VBN	associate
with	IN	with
the	DT	the
presence	NN	presence
of	IN	of
the	DT	the
rheumatoid	NN	rheumatoid
factor	NN	factor
.	.	.
</s>
<s type="decl">
The	DT	the
amount	NN	amount
of	IN	of
MPs	NNP	MPs
was	VBD	be
also	RB	also
associated	VBN	associate
with	IN	with
the	DT	the
presence	NN	presence
of	IN	of
traditional	JJ	traditional
cardiovascular	JJ	cardiovascular
risk	NN	risk
factors	NNS	factor
.	.	.
</s>
<s type="sub">
The	DT	the
findings	NNS	finding
of	IN	of
Cloutier	NNP	Cloutier
et	FW	et
al.	FW	al.
could	MD	could
indicate	VB	indicate
the	DT	the
possibility	NN	possibility
of	IN	of
using	VBG	use
the	DT	the
studies	NNS	study
of	IN	of
circulating	VBG	circulate
mpICs	NNS	mpic
to	TO	to
assess	VB	assess
RA	NN	RA
activity	NN	activity
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
different	JJ	different
conclusions	NNS	conclusion
were	VBD	be
presented	VBN	present
by	IN	by
van	NNP	van
Eijk	NNP	Eijk
et	FW	et
al.	NNP	al.
based	VBN	base
on	IN	on
a	DT	a
study	NN	study
with	IN	with
24	CD	24
patients	NNS	patient
with	IN	with
an	DT	a
early	JJ	early
form	NN	form
of	IN	of
RA	NNP	RA
.	.	.
</s>
<s type="decl">
The	DT	the
disease	NN	disease
activity	NN	activity
was	VBD	be
assessed	VBN	assess
based	VBN	base
on	IN	on
the	DT	the
ESR	NNP	ESR
,	,	,
C-reactive	NNP	C-reactive
protein	NN	protein
(	-LRB-	(
CRP	NNP	CRP
)	-RRB-	)
level	NN	level
,	,	,
and	CC	and
DAS28	NNP	DAS28
score	NN	score
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
the	DT	the
level	NN	level
of	IN	of
serum	NN	serum
amyloid-P	NN	amyloid-P
(	-LRB-	(
SAP	NNP	SAP
)	-RRB-	)
and	CC	and
the	DT	the
amount	NN	amount
of	IN	of
circulating	VBG	circulate
MPs	NNS	MP
and	CC	and
MPs	NNS	MP
presenting	VBG	present
the	DT	the
C1q	NNP	C1q
complement	NN	complement
component	NN	component
was	VBD	be
determined	VBN	determine
in	IN	in
the	DT	the
patients	NNS	patient
.	.	.
</s>
<s type="decl">
Nine	CD	9
patients	NNS	patient
were	VBD	be
reassessed	VBN	reass
after	IN	after
an	DT	a
eight-week	NN	eight-week
intensive	JJ	intensive
treatment	NN	treatment
according	VBG	accord
to	IN	to
the	DT	the
COBRA	NNP	Cobra
(	-LRB-	(
COmBination	NNP	COmBination
therapy	NN	therapy
in	IN	in
Rheumatoid	NNP	Rheumatoid
Arthritis	NNP	Arthritis
)	-RRB-	)
regimen	NN	regimen
,	,	,
which	WDT	which
included	VBD	include
a	DT	a
combined	VBN	combine
treatment	NN	treatment
with	IN	with
methotrexate	NN	methotrexate
,	,	,
sulfasalazine	NN	sulfasalazine
,	,	,
and	CC	and
prednisolone	NN	prednisolone
.	.	.
</s>
<s type="decl">
As	IN	as
expected	VBN	expect
,	,	,
ESR	NNP	ESR
,	,	,
CRP	NN	CRP
,	,	,
and	CC	and
DAS28	NNP	DAS28
improved	VBD	improve
as	IN	as
a	DT	a
result	NN	result
of	IN	of
the	DT	the
treatment	NN	treatment
;	:	;
however	RB	however
,	,	,
contrary	JJ	contrary
to	IN	to
expectations	NNS	expectation
,	,	,
neither	CC	neither
the	DT	the
amount	NN	amount
of	IN	of
circulating	VBG	circulate
MPs	NNP	MPs
,	,	,
nor	CC	nor
MPs	NNS	MP
with	IN	with
the	DT	the
attached	VBN	attach
C1q	NNP	C1q
component	NN	component
decreased	VBD	decrease
,	,	,
which	WDT	which
suggests	VBZ	suggest
the	DT	the
absence	NN	absence
of	IN	of
any	DT	any
connection	NN	connection
between	IN	between
the	DT	the
activity	NN	activity
of	IN	of
inflammation	NN	inflammation
and	CC	and
MPs	NNP	MPs
release	NN	release
and	CC	and
mpIC	NN	mpIC
production	NN	production
.	.	.
</s>
<s type="decl">
In	IN	in
a	DT	a
recent	JJ	recent
paper	NN	paper
,	,	,
Chen	NNP	Chen
demonstrated	VBD	demonstrate
that	IN	that
inhibition	NN	inhibition
of	IN	of
PMPs	NN	PMP
formation	NN	formation
in	IN	in
an	DT	a
animal	NN	animal
model	NN	model
of	IN	of
CIA	NNP	CIA
(	-LRB-	(
collagen-induced	JJ	collagen-induced
arthritis	NN	arthritis
)	-RRB-	)
and	CC	and
reduction	NN	reduction
of	IN	of
circulating	VBG	circulate
PMPs	NNS	PMP
was	VBD	be
associated	VBN	associate
with	IN	with
a	DT	a
clinical	JJ	clinical
decrease	NN	decrease
in	IN	in
the	DT	the
disease	NN	disease
activity	NN	activity
assessed	VBN	assess
as	IN	as
joint	JJ	joint
swelling	NN	swelling
and	CC	and
stiffness	NN	stiffness
.	.	.
</s>
</p>
</text>